Advances in Systemic Sclerosis with Interstitial Lung Disease (SSc-ILD) Management and the Role of the Clinical Pharmacist

Tuesday, December 6, 2022

2:10 PM – 2:15 PM

Location: Mandalay Bay South Convention Center, Mandalay Bay H, Level 2

CE Credits: 2.00 contact hours

Activity #: 0204-0000-22-295-L01-P
Activity Type: Knowledge-based

Learning Objectives:

Describe the impact of a clinical pharmacist in managing SSC-ILD management as part of an interdisciplinary care team.

Amanuel Kehasse, PharmD, PhD (he/him/his)

Manager – Clinical Programs
Clearway Health